Skip to content

Aquestive Therapeutics, Inc. AQST Proceeds from common stock issued under public equity offering-ATM, net

Proceeds from common stock issued under public equity offering-ATM, net at other companies

Red Cat Holdings, Inc. logo
Red Cat Holdings, Inc.RCAT
$0
GTY
Getty RealtyGTY
$19.92M+80.9%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$12.11M
Bit Digital logo
Bit DigitalBTBT
$4.11M-59.6%
Gryphon Digital Mining, Inc. logo
Gryphon Digital Mining, Inc.ABTC
$110.5M
UMH
UMH PropertiesUMH
$0-100%

Other financials

Income statement

See full
Revenue$14.4M+65.7%
Gross profit$11.0M+117%
Operating income-$4.2M+78.3%
Net income-$8.1M+64.9%
EPS (diluted)-$0.07+70.8%

Balance sheet

See full
Cash & equivalents$110.7M+61.3%
Total debt$64.4M+7.4%
Total equity-$34.1M+44.1%
Total assets$141.1M+38.0%

Cash flow

See full
Operating cash flow-$14.8M+36.7%
CapEx$52.0K-61.5%
Free cash flow-$14.9M+36.9%

Valuation

See full
Market cap$560.13M+73.5%
Enterprise value$513.76M+63.6%
P/S11.1×+5.2×

Profitability

See full
Gross margin63.5%-4.9pp
Operating margin-111.2%+96.3pp
Net margin-137.1%+80.7pp
FCF margin-88.2%-2.2pp

Returns & leverage

See full
Return on equity145.1%
Debt / equity-1.9×
Current ratio4.1×-0.8×

Where this comes from

Reported directly by Aquestive Therapeutics, Inc. in its filing.

Tagged under the XBRL concept aqst:ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises.

The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aquestive Therapeutics, Inc.'s proceeds from common stock issued under public equity offering-atm, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aquestive Therapeutics, Inc.'s proceeds from common stock issued under public equity offering-atm, net?
Aquestive Therapeutics, Inc. (AQST) reported proceeds from common stock issued under public equity offering-atm, net of $4.76M in Q1 2026.
How has Aquestive Therapeutics, Inc.'s proceeds from common stock issued under public equity offering-atm, net changed year-over-year?
Aquestive Therapeutics, Inc.'s proceeds from common stock issued under public equity offering-atm, net decreased by 77.7% year-over-year, from $21.36M to $4.76M.
What is the long-term trend for Aquestive Therapeutics, Inc.'s proceeds from common stock issued under public equity offering-atm, net?
Over 3 years (2021 to 2024), Aquestive Therapeutics, Inc.'s proceeds from common stock issued under public equity offering-atm, net has grown at a -26.6% compound annual growth rate (CAGR), from $29.78M to $11.78M.
What does proceeds from common stock issued under public equity offering-atm, net mean?
Reflects the net cash inflows generated from the sale of common stock through At-The-Market (ATM) equity offering programs. This serves as a flexible capital-raising mechanism that allows the company to issue shares periodically to fund research, development, and general corporate operations.